New treatments to fight a rare disorder wreaking havoc in isolated indigenous communities

August 11, 2017, Macquarie University

Macquarie University researchers have developed the first zebrafish model of the neurodegenerative Machado-Joseph Disease – and have used this model to test drugs that could potentially be used to treat the disease, which disproportionately affects Indigenous Australians.

Machado-Joseph Disease, or spinocerebellar ataxia-3, is a caused by a , which leads to a progressive loss of muscle control and movement. Most people living with MJD are wheelchair bound and need constant support within 15 years of symptoms first emerging.

Researchers gave the the human -causing gene, creating the first transgenic of MJD, allowing them to compare the movement, pathology and lifespan of fish carrying the healthy version of the human gene to those with the disease-causing version.

"Zebrafish are small and transparent, allowing us to see how a disease develops. Being able to use zebrafish to MJD is a great win for those of us working to develop treatments for this debilitating disease," said lead author Dr Angela Laird, a Biomedical Sciences Research Fellow at Macquarie University.

"Children of people living with MJD have a 50 percent chance of having the condition, and may experience more severe symptoms, at a younger age. It goes without saying that we need to do more to support people living with the condition."

As zebrafish absorb medicines added to the water they swim in, the team went on to test the effect of treating the zebrafish with a substance called calpeptin– and found that it removed most of the disease-causing .

"These results were even more promising than we had anticipated. The calpeptin didn't just remove fragments of the disease-causing protein, but the whole protein itself," added Dr Laird.

"We found that the calpeptin treatment triggered autophagy – a process by which toxic proteins in the body are removed. Once the disease-causing protein was removed, we saw improvements in the movement of the zebrafish with MJD.

"Drugs that trigger the autophagy process could be a promising way to treat not only Machado-Joseph Disease, but also other diseases. Thanks to this model, we can continue to test calpeptin and other related drugs relatively quickly, ultimately contributing to the future development of an effective treatment for the disease."

Explore further: Zebrafish study leads to potential treatment for muscle disease

Related Stories

Zebrafish study leads to potential treatment for muscle disease

April 22, 2016
The tiny zebrafish has been used by Monash University researchers to identify a potential approach to treating the progressive and devastating muscle disease, myofibrillar myopathy. The findings may also be useful for diseases ...

Genetically modifying zebrafish for detection of harmful compounds in drug candidates

July 26, 2017
The common zebrafish is a useful proxy for testing whether drug candidates cause organ damage. Now, researchers in Singapore have created two modified types of the fish, one that glows when experiencing toxicity, and another ...

A novel zebrafish model enables genetic studies of Hirschsprung disease

January 12, 2017
Researchers led by the Francis Crick Institute have developed a zebrafish model of a human disease - Hirschsprung disease - that enables them to study the disease's causes and consequences in living animals and will help ...

Research could give insight into genetic basis of of the human muscle disease, myopathy

July 5, 2017
Pioneering research using the tropical zebrafish could provide new insights into the genetic basis of myopathy, a type of human muscle disease.

Zebrafish help identify mutant gene in rare muscle disease

June 4, 2013
Zebrafish with very weak muscles helped scientists decode the elusive genetic mutation responsible for Native American myopathy, a rare, hereditary muscle disease that afflicts Native Americans in North Carolina.

Zebrafish discovery could hold the key to better understanding motor neuron disease

February 13, 2017
Researchers from Macquarie University's MQ Health are the first in the world to use a refined UV laser ablation technique to study the cellular behavior of MND in living zebrafish. New findings, published in the Journal of ...

Recommended for you

New hope for cystic fibrosis

October 19, 2018
A new triple-combination drug treatment being trialled at the Mater Hospital in Brisbane could increase the life expectancy of patients with cystic fibrosis.

Bug guts shed light on Central America Chagas disease

October 18, 2018
In Central America, Chagas disease, or American trypanosomiasis, is spread by the "kissing bug" Triatoma dimidiata. By collecting DNA from the guts of these bugs, researchers reporting in PLOS Neglected Tropical Diseases ...

Rapid genomic sequencing of Lassa virus in Nigeria enabled real-time response to 2018 outbreak

October 18, 2018
Mounting a collaborative, real-time response to a Lassa fever outbreak in early 2018, doctors and scientists in Nigeria teamed up with researchers at Broad Institute of MIT and Harvard and colleagues to rapidly sequence the ...

Researchers cure drug-resistant infections without antibiotics

October 17, 2018
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria ...

Infectious disease consultation significantly reduces mortality of patients with bloodstream yeast infections

October 17, 2018
In a retrospective cohort study conducted at the University of Alabama at Birmingham Division of Infectious Diseases, patients with candidemia—a yeast infection in the bloodstream—had more positive outcomes as they relate ...

How drug resistant TB evolved and spread globally

October 17, 2018
The most common form of Mycobacterium tuberculosis (TB) originated in Europe and spread to Asia, Africa and the Americas with European explorers and colonialists, reveals a new study led by UCL and the Norwegian Institute ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.